A cohort analysis of familial partial lipodystrophy from two Mediterranean countries
Diabetes, Obesity and Metabolism · 2024-11 · 26 (11) · 4875-4886
DOI: 10.1111/dom.15882 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 22.08.2024. Verfasst von Antía Fernández-Pombo und 14 weiteren Autor:innen. Beteiligte Einrichtung: UETeM-Molecular Pathology Group, Department of Psychiatry, Radiology, Public Health, Nursing and Medicine, IDIS-CIMUS, University of Santiago de Comp…. Hauptthemen laut MEDLINE: Lipodystrophy, Familial Partial. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Secretaria Xeral de Investigación e Desenvolvemento, Xunta de Galicia, Asociación Española de Familiares y Afectados de Lipodistrofias, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Aim
To assess the disease burden of familial partial lipodystrophy (FPLD) caused by LMNA (FPLD2) and PPARG (FPLD3) variants to augment the knowledge of these rare disorders characterized by selective fat loss and metabolic complications. Materials and Methods An observational longitudinal study, including 157 patients (FPLD2: 139 patients, mean age 46 ± 17 years, 70% women; FPLD3: 18 patients, mean age: 44 ± 17 years, 78% women) from 66 independent families in two countries (83 from Turkey and 74 from Spain), was conducted.
Results
Patients were diagnosed at a mean age of 39 ± 19 years, 20 ± 16 years after the first clinical signs appeared. Men reported symptoms later than women. Symptom onset was earlier in FPLD2. Fat loss was less prominent in FPLD3. In total, 92 subjects (59%) had diabetes (age at diagnosis: 34 ± 1 years). Retinopathy was more commonly detected in FPLD3 ( P < .05). Severe hypertriglyceridaemia was more frequent among patients with FPLD3 (44% vs. 17%, P = .01). Hepatic steatosis was detected in 100 subjects (66%) (age at diagnosis: 36 ± 2 years). Coronary artery disease developed in 26 patients (17%) and 17 (11%) suffered from a myocardial infarction. Turkish patients had a lower body mass index, a higher prevalence of hepatic steatosis, greater triglyceride levels and a tendency towards a higher prevalence of coronary artery disease. A total of 17 patients died, with a mean time to death of 75 ± 3 years, which was shorter in the Turkish cohort (68 ± 2 vs. 83 ± 4 years, P = .01). Cardiovascular events were a major cause of death.
Conclusions
Our analysis highlights severe organ complications in patients with FPLD, showing differences between genotypes and Mediterranean countries. FPLD3 presents a milder phenotype than FPLD2, but with comparable or even greater severity of metabolic disturbances.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UETeM-Molecular Pathology Group, Department of Psychiatry, Radiology, Public Health, Nursing and Medicine, IDIS-CIMUS, University of Santiago de Compostela, Santiago, Spain.
- Division of Endocrinology and Nutrition, University Clinical Hospital of Santiago de Compostela, Santiago, Spain.
- Division of Endocrinology and Metabolism Disorders, Department of Internal Medicine, Ege University Medical Faculty, Izmir, Turkey.
- Department of Pediatric Endocrinology, Faculty of Medicine, Ege University, İzmir, Turkey.
- CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), Madrid, Spain.
- Department of Medical Genetics, Ege University Faculty of Medicine, Izmir, Turkey.
ORCID-Profile: Baris Akinci, David Araújo-Vilar
Förderung
- Secretaria Xeral de Investigación e Desenvolvemento, Xunta de Galicia
- Asociación Española de Familiares y Afectados de Lipodistrofias
- Instituto de Salud Carlos III
- Fundación Alfonso Martín Escudero
- Juan Rodés research contract
- ERDF
- European Regional Development Fund
Zitieren
APA
Fernández-Pombo, A., Yildirim Simsir, I., Sánchez-Iglesias, S., Ozen, S., Castro, A. I., Atik, T., Loidi, L., Onay, H., Prado-Moraña, T., Adiyaman, C., Díaz-López, E. J., Altay, C., Ginzo-Villamayor, M. J., Akinci, B., & Araújo-Vilar, D. (2024). A cohort analysis of familial partial lipodystrophy from two Mediterranean countries. Diabetes, Obesity and Metabolism, 26(11), 4875-4886. https://doi.org/10.1111/dom.15882
Vancouver
Fernández-Pombo A, Yildirim Simsir I, Sánchez-Iglesias S, Ozen S, Castro AI, Atik T, et al. A cohort analysis of familial partial lipodystrophy from two Mediterranean countries. Diabetes, Obesity and Metabolism. 2024;26(11):4875-4886. doi:10.1111/dom.15882
BibTeX
@article{FernndezPombo2024,
author = {Fernández-Pombo, Antía and Yildirim Simsir, Ilgin and Sánchez-Iglesias, Sofía and Ozen, Samim and Castro, Ana I and Atik, Tahir and Loidi, Lourdes and Onay, Huseyin and Prado-Moraña, Teresa and Adiyaman, Cem and Díaz-López, Everardo Josué and Altay, Canan and Ginzo-Villamayor, Maria José and Akinci, Baris and Araújo-Vilar, David},
title = {A cohort analysis of familial partial lipodystrophy from two Mediterranean countries},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
volume = {26},
number = {11},
pages = {4875--4886},
doi = {10.1111/dom.15882}
}
EUVIMED